Pharma Gets Win in Court Appeal Over Maryland Drug Discount Law

AbbVie Inc., Novartis AG, AstraZeneca Plc, and drug industry group PhRMA notched a victory Tuesday after a federal appeals court vacated an order rejecting their request to block a Maryland drug discount law, remanding the decision for review.

The US Court of Appeals for the Fourth Circuit ruled a lower court “erred” when it denied the drugmakers and the Pharmaceutical Research and Manufacturers of America’s motion for a preliminary injunction against Maryland’s H.B. 1056. The law, currently in effect, requires manufacturers to distribute discounted drugs to an unlimited number of pharmacies that contract with health providers under ...

Read more at Bloomberg Law.